Blood test offers hope for more effective ovarian cancer treatment Media Release - 12 November 2025 New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment [...]
New report reveals Australia’s fastest-growing women’s cancer Uterine cancers have become Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25 years and projected to continue to surge. Without immediate action, more than 44,000 women are expected [...]
ANZGOG releases co-authored position paper on uterine cancer “Spotlight on uterine cancer: Shaping access to equitable and high-quality care” Uterine cancer is the most common gynecological cancer in Australia – and the second most common globally. Despite this, [...]
Professor Paul Cohen presents highlights from the recent ASCO Annual Meeting held in Chicago, USA, from May 30 – June 3, 2025. The American Society of Clinical Oncology (ASCO) is the leading professional organisation for [...]
The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. ASCO offers premier scientific events for oncology professionals, patient advocates, industry representatives, and [...]
Professor Paul Cohen and Associate Professor Yoland Antill present highlights from the recent ESGO's 25th Congress held in Barcelona, Spain, from March 7-10, 2024. What is ESGO? The European Society of Gynaecological Oncology (ESGO) is [...]
Patient involvement in research within the Gynecologic Cancer InterGroup: A call to action for a systematic approach: Results from a survey Patient involvement in clinical research development has gradually expanded over the last two decades, creating [...]
ANZGOG Chair, Professor Clare Scott AM presents highlights from the recent ESMO conference, held in Madrid, Spain, 20-24 October 2023. What is ESMO 2023? To stay at the forefront of clinical trial opportunities for our [...]
Explore a curated selection of publications and presentations from the American Society of Clinical Oncology (ASCO) meeting held in June, 2023. These insights, chosen by Assoc Prof Yoland Antill, Deputy Chair of ANZGOG's RAC have the [...]
The results of the OUTBACK trial, a landmark multinational phase 3 trial investigating the efficacy of adjuvant chemotherapy in women with locally advanced cervical cancer, have been published in The Lancet Oncology. The trial aimed [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2025 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
